WO2006007227A3 - Cannabidiols anormaux utilises comme agents pour abaisser la pression intraoculaire et apporter un effet neuroprotecteur a l'oeil - Google Patents

Cannabidiols anormaux utilises comme agents pour abaisser la pression intraoculaire et apporter un effet neuroprotecteur a l'oeil Download PDF

Info

Publication number
WO2006007227A3
WO2006007227A3 PCT/US2005/018830 US2005018830W WO2006007227A3 WO 2006007227 A3 WO2006007227 A3 WO 2006007227A3 US 2005018830 W US2005018830 W US 2005018830W WO 2006007227 A3 WO2006007227 A3 WO 2006007227A3
Authority
WO
WIPO (PCT)
Prior art keywords
intraocular pressure
lowering intraocular
abnormal cannabidiols
formula
cannabidiols
Prior art date
Application number
PCT/US2005/018830
Other languages
English (en)
Other versions
WO2006007227A2 (fr
Inventor
June Chen
David F Woodward
Original Assignee
Allergan Inc
June Chen
David F Woodward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/874,441 external-priority patent/US20050282913A1/en
Priority claimed from US10/874,440 external-priority patent/US20050282912A1/en
Priority claimed from US11/073,209 external-priority patent/US20050282902A1/en
Priority claimed from US11/121,528 external-priority patent/US20060247321A1/en
Application filed by Allergan Inc, June Chen, David F Woodward filed Critical Allergan Inc
Priority to EP05784443A priority Critical patent/EP1765315A2/fr
Priority to JP2007518081A priority patent/JP2008503577A/ja
Priority to BRPI0512525-1A priority patent/BRPI0512525A/pt
Priority to CA002570853A priority patent/CA2570853A1/fr
Publication of WO2006007227A2 publication Critical patent/WO2006007227A2/fr
Publication of WO2006007227A3 publication Critical patent/WO2006007227A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des cannabidiols anormaux utilisés comme hypotenseurs oculaires puissants, qui sont particulièrement appropriés pour le traitement du glaucome. L'invention concerne en particulier des composés de formule (I) ou de formule (II) ou de formule (III), dont il a été également découvert qu'ils apportent un effet neuroprotecteur à l'oeil.
PCT/US2005/018830 2004-06-22 2005-05-26 Cannabidiols anormaux utilises comme agents pour abaisser la pression intraoculaire et apporter un effet neuroprotecteur a l'oeil WO2006007227A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP05784443A EP1765315A2 (fr) 2004-06-22 2005-05-26 Cannabidiols anormaux pour abaisser la pression intraoculaire
JP2007518081A JP2008503577A (ja) 2004-06-22 2005-05-26 眼圧を降下するためのアブノーマル・カンナビジオール化合物
BRPI0512525-1A BRPI0512525A (pt) 2004-06-22 2005-05-26 canabidióis anormais como agentes para diminuir a pressão intraocular e fornecer efeito neuroprotetor ao olho
CA002570853A CA2570853A1 (fr) 2004-06-22 2005-05-26 Cannabidiols anormaux utilises comme agents pour abaisser la pression intraoculaire et apporter un effet neuroprotecteur a l'oeil

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10/874,441 US20050282913A1 (en) 2004-06-22 2004-06-22 Abnormal cannabidiols as agents for lowering intraocular pressure
US10/874,440 US20050282912A1 (en) 2004-06-22 2004-06-22 Abnormal cannabidiols as neuroprotective agents for the eye
US10/874,440 2004-06-22
US10/874,441 2004-06-22
US11/073,209 US20050282902A1 (en) 2004-06-22 2005-03-05 Abnormal cannabidiols as agents for lowering intraocular pressure
US11/073,209 2005-03-05
US11/121,528 US20060247321A1 (en) 2005-05-02 2005-05-02 Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure
US11/121,528 2005-05-02

Publications (2)

Publication Number Publication Date
WO2006007227A2 WO2006007227A2 (fr) 2006-01-19
WO2006007227A3 true WO2006007227A3 (fr) 2006-05-18

Family

ID=35462212

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/018830 WO2006007227A2 (fr) 2004-06-22 2005-05-26 Cannabidiols anormaux utilises comme agents pour abaisser la pression intraoculaire et apporter un effet neuroprotecteur a l'oeil

Country Status (6)

Country Link
EP (1) EP1765315A2 (fr)
JP (1) JP2008503577A (fr)
AU (1) AU2005262652A1 (fr)
BR (1) BRPI0512525A (fr)
CA (1) CA2570853A1 (fr)
WO (1) WO2006007227A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968711B2 (en) 2006-04-24 2011-06-28 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7618966B2 (en) 2006-04-24 2009-11-17 Allergan, Inc. Abnormal Cannabidiols as agents for lowering intraocular pressure
US7718830B2 (en) 2006-04-24 2010-05-18 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7612101B2 (en) 2006-04-24 2009-11-03 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
CA3091088A1 (fr) * 2018-02-13 2019-08-22 Beetlebung Pharma Ltd. Derives et conjugues de cannabinoides et leurs utilisations
CN115006404A (zh) * 2022-08-09 2022-09-06 昆药集团股份有限公司 一种具有视神经保护功效的药物组合物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939429A (en) * 1997-09-30 1999-08-17 Virginia Commonwealth University Cardiovascular uses of cannabinoid compounds
WO2001003690A1 (fr) * 1999-07-12 2001-01-18 Virginia Commonwealth University Nouveaux analogues de cannabinoides vasodilatateurs
WO2003091189A1 (fr) * 2002-04-25 2003-11-06 Virginia Commonwealth University Cannabinoides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939429A (en) * 1997-09-30 1999-08-17 Virginia Commonwealth University Cardiovascular uses of cannabinoid compounds
WO2001003690A1 (fr) * 1999-07-12 2001-01-18 Virginia Commonwealth University Nouveaux analogues de cannabinoides vasodilatateurs
WO2003091189A1 (fr) * 2002-04-25 2003-11-06 Virginia Commonwealth University Cannabinoides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
COMPTON, DAVID R. ET AL: "Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogs of 10-substituted cannabidiol and 11- or 12-substituted .DELTA.8-tetrahydrocannabinol", JOURNAL OF MEDICINAL CHEMISTRY , 33(5), 1437-43 CODEN: JMCMAR; ISSN: 0022-2623, 1990, XP001076889 *
HO, W.-S. VANESSA ET AL: "Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery", BRITISH JOURNAL OF PHARMACOLOGY , 138(7), 1320-1332 CODEN: BJPCBM; ISSN: 0007-1188, 2003, XP008060537 *
ULISS, D. B. ET AL: "Hashish. Importance of the phenolic hydroxyl group in tetrahydrocannabinols", JOURNAL OF MEDICINAL CHEMISTRY , 18(2), 213-15 CODEN: JMCMAR; ISSN: 0022-2623, 1975, XP008060536 *

Also Published As

Publication number Publication date
AU2005262652A1 (en) 2006-01-19
EP1765315A2 (fr) 2007-03-28
WO2006007227A2 (fr) 2006-01-19
JP2008503577A (ja) 2008-02-07
BRPI0512525A (pt) 2008-03-11
CA2570853A1 (fr) 2006-01-19

Similar Documents

Publication Publication Date Title
WO2006044425A3 (fr) Compositions ophtalmiques de traitement de l'hypertension oculaire
WO2005002520A3 (fr) Compositions ophtalmiques destinees au traitement d'hypertension oculaire
WO2006062731A8 (fr) Utilisation de la phenanthroline et de ses derives pour abaisser la tension intraoculaire d'un oeil affecte
WO2007108968A3 (fr) Compositions ophtalmiques pour le traitement de l'hypertension oculaire
WO2007076360A8 (fr) (indazol-5-yl)-pyrazines et (1,3-dihydro-indol-2-un)- pyrazines pour le traitement de maladies et de conditions a mediation de rho kinase
WO2006101839A3 (fr) Solution ophtalmique de bimatoprost amelioree
WO2007136759A3 (fr) Procédé de traitement et de prévention de troubles oculaires
WO2006072393A3 (fr) Sulfonylpyrrolidines, procede pour les produire et leur utilisation comme medicaments
WO2006099943A8 (fr) 8-n-benzimidazoles a substitution amide, leur procede de production, et leur utilisation en tant que medicaments
WO2006105403A3 (fr) Traitement de troubles oculaires par modulateurs de sirtuine
WO2007140385A3 (fr) Nouveaux composés en tant que ligands des récepteurs des cannabinoïdes et utilisations de ceux-ci
WO2006127987A3 (fr) Traitement de troubles oculaires par modulateurs de sirtuine
WO2006021379A8 (fr) Derives de dihydropteridinone, procedes pour les produire et utilisation de ceux-ci comme medicaments
WO2006021378A8 (fr) Derives de dihydropteridinone, procede pour les produire et utilisation de ceux-ci comme medicaments
EP3542629A3 (fr) Composés dithiols, dérivés et leurs utilisations
WO2007062999A3 (fr) Derives de indole-2-yl amide substitues en 1,5
WO2007021937A3 (fr) Derives heterocycliques insatures
WO2008040649A3 (fr) Dérivés de pyrazine-2-carboxamide
WO2006072458A3 (fr) Derives d'oxindol substitues, agents pharmaceutiques les contenant, et leur utilisation
WO2009111633A3 (fr) Composés mercaptan et séléno-mercaptan et procédé d’utilisation de ceux-ci
NO20082096L (no) Azaindol-2-karboksamidderivativer
WO2006066950A3 (fr) Aminoalcools tricycliques, procedes de realisation associes et utilisation comme anti-inflammatoires
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
WO2006007227A3 (fr) Cannabidiols anormaux utilises comme agents pour abaisser la pression intraoculaire et apporter un effet neuroprotecteur a l'oeil
WO2009074247A8 (fr) Nouveaux dérivés d'amide d'acide 2-arylthiazole-4-carboxylique, leur préparation et leur utilisation en tant que médicament

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005262652

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2570853

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2005784443

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007518081

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

ENP Entry into the national phase

Ref document number: 2005262652

Country of ref document: AU

Date of ref document: 20050526

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005262652

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005784443

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0512525

Country of ref document: BR